A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Icon PLC stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 1,753 shares of ICLR stock, worth $373,844. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,753
Previous 1,942 9.73%
Holding current value
$373,844
Previous $609,000 17.24%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$280.48 - $346.2 $53,010 - $65,431
-189 Reduced 9.73%
1,753 $504,000
Q2 2024

Jul 26, 2024

SELL
$288.23 - $331.73 $127,974 - $147,288
-444 Reduced 18.61%
1,942 $609,000
Q1 2024

Apr 24, 2024

BUY
$247.84 - $340.0 $111,528 - $153,000
450 Added 23.24%
2,386 $802,000
Q4 2023

Feb 09, 2024

BUY
$222.83 - $285.76 $25,848 - $33,148
116 Added 6.37%
1,936 $548,000
Q3 2023

Oct 24, 2023

SELL
$236.44 - $265.62 $33,574 - $37,718
-142 Reduced 7.24%
1,820 $448,000
Q2 2023

Jul 13, 2023

SELL
$183.12 - $250.2 $21,791 - $29,773
-119 Reduced 5.72%
1,962 $491,000
Q1 2023

May 11, 2023

BUY
$193.59 - $245.33 $13,744 - $17,418
71 Added 3.53%
2,081 $444,000
Q4 2022

Feb 08, 2023

BUY
$173.9 - $224.8 $12,520 - $16,185
72 Added 3.72%
2,010 $390,000
Q3 2022

Oct 17, 2022

SELL
$183.25 - $247.5 $6,230 - $8,415
-34 Reduced 1.72%
1,938 $356,000
Q2 2022

Jul 13, 2022

SELL
$197.3 - $261.32 $139,688 - $185,014
-708 Reduced 26.42%
1,972 $427,000
Q1 2022

May 12, 2022

BUY
$216.09 - $296.03 $42,137 - $57,725
195 Added 7.85%
2,680 $651,000
Q4 2021

Feb 03, 2022

BUY
$258.11 - $309.7 $64,527 - $77,425
250 Added 11.19%
2,485 $769,000
Q3 2021

Nov 02, 2021

SELL
$208.53 - $283.04 $276,719 - $375,594
-1,327 Reduced 37.25%
2,235 $585,000
Q2 2021

Aug 10, 2021

SELL
$194.07 - $232.2 $201,056 - $240,559
-1,036 Reduced 22.53%
3,562 $736,000
Q1 2021

May 07, 2021

BUY
$171.87 - $220.96 $283,757 - $364,804
1,651 Added 56.02%
4,598 $902,000
Q4 2020

Feb 04, 2021

SELL
$180.3 - $214.08 $2,524 - $2,997
-14 Reduced 0.47%
2,947 $574,000
Q3 2020

Oct 29, 2020

SELL
$166.91 - $196.1 $13,185 - $15,491
-79 Reduced 2.6%
2,961 $565,000
Q2 2020

Jul 27, 2020

SELL
$129.79 - $170.94 $12,979 - $17,094
-100 Reduced 3.18%
3,040 $512,000
Q1 2020

May 08, 2020

SELL
$115.95 - $177.22 $6,261 - $9,569
-54 Reduced 1.69%
3,140 $427,000
Q4 2019

Feb 04, 2020

SELL
$139.48 - $172.23 $5,997 - $7,405
-43 Reduced 1.33%
3,194 $550,000
Q3 2019

Nov 06, 2019

BUY
$146.89 - $161.41 $273,802 - $300,868
1,864 Added 135.76%
3,237 $476,000
Q3 2019

Oct 28, 2019

BUY
$146.89 - $161.41 $1,028 - $1,129
7 Added 0.51%
1,373 $202,000
Q2 2019

Aug 15, 2019

BUY
$129.99 - $153.97 $177,566 - $210,323
1,366 New
1,366 $0

Others Institutions Holding ICLR

About ICON PLC


  • Ticker ICLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 81,526,600
  • Market Cap $17.4B
  • Description
  • ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...
More about ICLR
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.